| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
a Institut für Genetik und Allgemeine Biologie, Universität Salzburg, Salzburg A-5020, Austria
b EMBL-Heidelberg D-69012, Germany
c Novartis Forschungsinstitut, A-1235 Vienna, Austria
d Hewlett-Packard Analytical Group, Waldbronn D-76337, Germany
e Institut für Allgemeine und Experimentelle Pathologie, Universität Wien, Vienna A-1090, Austria
Specific immunotherapy is an efficient treatment for patients suffering from type I allergy. The mechanisms underlying successful immunotherapy are assumed to operate at the level of T helper cells, leading to a modulation of the immune response to allergens. During immunotherapy, increasing doses of allergens are given on a regular basis, and the beneficial effects for the patient depend on the concentration of allergen used. On the other hand, the risk of IgE-mediated anaphylactic side effects also increase with the amount of allergen applied per injection. Therefore, we have proposed the use of hypoallergenic (low IgE binding activity) forms of allergens for immunotherapy. We evaluated by site-directed mutagenesis the contributions of individual amino acid residues/positions for IgE binding to Bet v 1, the major allergen of birch pollen. We found that IgE binding to Bet v 1 depended on at least six amino acid residues/positions. Immunoblot analyses and inhibition experiments showed that the multiple-point Bet v 1 mutant exhibited extremely low reactivity with serum IgE from birch pollen-allergic patients. In vivo (skin prick) tests showed that the potency of the multiple-point mutant to induce typical urticarial type I reactions in pollen-allergic patients was significantly lower than for wild-type Bet v 1. Proliferation assays of allergen-specific T cell clones demonstrated that these six amino acid exchanges in the Bet v 1 sequence did not influence T cell recognition. Thus, the Bet v 1 six-point mutant displayed significantly reduced IgE binding activity, but conserved T cell activating capacity, which is necessary for immunomodulation. The approach described here may be generally applied to produce allergen variants to be used in a safe therapy form of immediate-type allergies.—Ferreira, F., Ebner, C., Kramer, B., Casari, G., Briza, P., Kungl, A. J., Grimm, R., Jahn-Schmid, B., Breiteneder, H., Kraft, D., Breitenbach, M., Rheinberger, H.-J., Scheiner, O. Modulation of IgE reactivity of allergens by site-directed mutagenesis: potential use of hypoallergenic variants for immunotherapy. FASEB J. 12, 231–242 (1998)
Key Words: major birch pollen allergen • Bet v 1 mutants • IgE binding epitopes • allergen-specific T cell clones • hypoallergens
This article has been cited by other articles:
|
|
 |
|
  D. E. Kean, H. S. Goodridge, S. McGuinness, M. M. Harnett, M. J. C. Alcocer, and W. Harnett Differential Polarization of Immune Responses by Plant 2S Seed Albumins, Ber e 1, and SFA8 J. Immunol., August 1, 2006; 177(3): 1561 - 1566. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Scholl, N. Kalkura, Y. Shedziankova, A. Bergmann, P. Verdino, R. Knittelfelder, T. Kopp, B. Hantusch, C. Betzel, K. Dierks, et al. Dimerization of the Major Birch Pollen Allergen Bet v 1 Is Important for its In Vivo IgE-Cross-Linking Potential in Mice J. Immunol., November 15, 2005; 175(10): 6645 - 6650. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Buhot, A. Chenal, A. Sanson, S. Pouvelle-Moratille, M. H. Gelb, A. Menez, D. Gillet, and B. Maillere Alteration of the tertiary structure of the major bee venom allergen Api m 1 by multiple mutations is concomitant with low IgE reactivity Protein Sci., November 1, 2004; 13(11): 2970 - 2978. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Y. Jeong, J. Lee, I.-Y. Lee, H.-I. Ree, C.-S. Hong, and T.-S. Yong Analysis of Amino Acid Sequence Variations and Immunoglobulin E-Binding Epitopes of German Cockroach Tropomyosin Clin. Vaccine Immunol., September 1, 2004; 11(5): 874 - 878. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Mairbaurl, F. Schwobel, S. Hoschele, M. Maggiorini, S. Gibbs, E. R. Swenson, and P. Bartsch Altered ion transporter expression in bronchial epithelium in mountaineers with high-altitude pulmonary edema J Appl Physiol, November 1, 2003; 95(5): 1843 - 1850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Spangfort, O. Mirza, H. Ipsen, R. J. J. van Neerven, M. Gajhede, and J. N. Larsen Dominating IgE-Binding Epitope of Bet v 1, the Major Allergen of Birch Pollen, Characterized by X-ray Crystallography and Site-Directed Mutagenesis J. Immunol., September 15, 2003; 171(6): 3084 - 3090. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nowak-Wegrzyn Future Approaches to Food Allergy Pediatrics, June 1, 2003; 111(6): 1672 - 1680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-M. Li, K. Srivastava, J. W. Huleatt, K. Bottomly, A. W. Burks, and H. A. Sampson Engineered Recombinant Peanut Protein and Heat-Killed Listeria monocytogenes Coadministration Protects Against Peanut-Induced Anaphylaxis in a Murine Model J. Immunol., March 15, 2003; 170(6): 3289 - 3295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Mairbaurl, J. Weymann, A. Mohrlein, E. R. Swenson, M. Maggiorini, J. S. R. Gibbs, and P. Bartsch Nasal Epithelium Potential Difference at High Altitude (4,559 m): Evidence for Secretion Am. J. Respir. Crit. Care Med., March 15, 2003; 167(6): 862 - 867. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Wodopia, H. S. Ko, J. Billian, R. Wiesner, P. Bartsch, and H. Mairbaurl Hypoxia decreases proteins involved in epithelial electrolyte transport in A549 cells and rat lung Am J Physiol Lung Cell Mol Physiol, December 1, 2000; 279(6): L1110 - L1119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. GANGLBERGER, K. GRÜNBERGER, B. SPONER, C. RADAUER, H. BREITENEDER, G. BOLTZ-NITULESCU, O. SCHEINER, and E. JENSEN-JAROLIM Allergen mimotopes for 3-dimensional epitope search and induction of antibodies inhibiting human IgE FASEB J, November 1, 2000; 14(14): 2177 - 2184. [Abstract] [Full Text]
|
|
|
|
|
|
M. Astori, C. von Garnier, A. Kettner, N. Dufour, G. Corradin, and F. Spertini Inducing Tolerance by Intranasal Administration of Long Peptides in Naive and Primed CBA/J Mice J. Immunol., September 15, 2000; 165(6): 3497 - 3505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. J. Huby, R. J. Dearman, and I. Kimber Why Are Some Proteins Allergens? Toxicol. Sci., June 1, 2000; 55(2): 235 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Texier, S. Pouvelle, M. Busson, M. Herve, D. Charron, A. Menez, and B. Maillere HLA-DR Restricted Peptide Candidates for Bee Venom Immunotherapy J. Immunol., March 15, 2000; 164(6): 3177 - 3184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Texier, M. Herve, S. Pouvelle, A. Menez, and B. Maillere On the diversity and heterogeneity of H-2d-restricted determinants and T cell epitopes from the major bee venom allergen Int. Immunol., August 1, 1999; 11(8): 1313 - 1326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. BALL, T. FUCHS, W. R. SPERR, P. VALENT, L. VANGELISTA, D. KRAFT, and R. VALENTA B cell epitopes of the major timothy grass pollen allergen, Phl p 1, revealed by gene fragmentation as candidates for immunotherapy FASEB J, August 1, 1999; 13(11): 1277 - 1290. [Abstract] [Full Text]
|
|
|
|
|
|
V. NIEDERBERGER, B. HAYEK, S. VRTALA, S. LAFFER, A. TWARDOSZ, L. VANGELISTA, W. R. SPERR, P. VALENT, H. RUMPOLD, D. KRAFT, et al. Calcium-dependent immunoglobulin E recognition of the apo- and calcium-bound form of a cross-reactive two EF-hand timothy grass pollen allergen, Phl p 7 FASEB J, May 1, 1999; 13(8): 843 - 856. [Abstract] [Full Text]
|
|
|
|
|
|
E. Jensen-jarolim, A. Leitner, H. Kalchhauser, A. Zürcher, E. Ganglberger, B. Bohle, O. Scheiner, G. Boltz-nitulescu, and H. Breiteneder Peptide mimotopes displayed by phage inhibit antibody binding to Bet v 1, the major birch pollen allergen, and induce specific IgG response in mice FASEB J, December 1, 1998; 12(15): 1635 - 1642. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. Neudecker, K. Schweimer, J. Nerkamp, S. Scheurer, S. Vieths, H. Sticht, and P. Rosch Allergic Cross-reactivity Made Visible. SOLUTION STRUCTURE OF THE MAJOR CHERRY ALLERGEN Pru av 1 J. Biol. Chem., June 15, 2001; 276(25): 22756 - 22763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Mairbaurl, K. Mayer, K.-J. Kim, Z. Borok, P. Bartsch, and E. D. Crandall Alveolar Epithelial Ion and Fluid Transport: Hypoxia decreases active Na transport across primary rat alveolar epithelial cell monolayers Am J Physiol Lung Cell Mol Physiol, April 1, 2002; 282(4): L659 - L665. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
